All PlansCoverageLow impact
Cryosurgical Ablation of Primary or Metastatic Liver Tumors
Blue Cross & Blue Shield of Mississippi·MS · General Surgery, Oncology, Gastroenterology·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy confirms that cryosurgical ablation of primary or metastatic liver tumors remains investigational and non-covered. The policy was recently updated with minor description changes but the coverage determination remains unchanged - these procedures will be denied as investigational.
Action Required
Continue to verify coverage for liver cryosurgical ablation procedures before scheduling. Inform patients that CPT codes 47371, 47381, and 47383 are considered investigational by BCBS and will likely be denied. Consider alternative covered treatments or obtain advance beneficiary notices if patients wish to proceed.